The SIRT1/MRPS4 axis is involved in metabolic reprogramming, facilitates tumor progression in HCC and plays a critical role in maintaining the stemness of liver cancer stem cells (CSCs) and participating in tumor progression [46]. The gene discussed is IMP3; the disease is hepatocellular carcinoma.